The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
120610414 12061041 4 F 20160722 20160210 20160815 PER US-ASTRAZENECA-2016SE10819 ASTRAZENECA 0.00 F Y 131.10000 KG 20160815 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
120610414 12061041 1 PS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) 160/4.5 MCG 120 INHALATIONS, TWO PUFFS TWICE A DAY 3001015C00,3001082C00 21929 BID
120610414 12061041 2 C PROVENTIL ALBUTEROL 1 Respiratory (inhalation) 0
120610414 12061041 3 C ZANTAC RANITIDINE HYDROCHLORIDE 1 Oral 0 150 MG BID
120610414 12061041 4 C LASIX FUROSEMIDE 1 Oral 0 80 MG QD
120610414 12061041 5 C COUMADIN WARFARIN SODIUM 1 Oral 0 5 MG
120610414 12061041 6 C COUMADIN WARFARIN SODIUM 1 Oral 0 2.5 MG /wk
120610414 12061041 7 C TYLENOL EXTRA STRENGTH ACETAMINOPHEN 1 Oral AS REQUIRED 0
120610414 12061041 8 C VITAMIN B6 PYRIDOXINE HYDROCHLORIDE 1 Oral 0 100 MG QD
120610414 12061041 9 C PRODUCT UNKNOWN 2 Oral 300.0MG UNKNOWN 0 300 MG CAPSULE
120610414 12061041 10 C FUROSEMIDE. FUROSEMIDE 1 0 10 MG QD
120610414 12061041 11 C FUROSEMIDE. FUROSEMIDE 1 0 20 MG QD
120610414 12061041 12 C FUROSEMIDE. FUROSEMIDE 1 0 40 MG QD
120610414 12061041 13 C VITAMIN B12 CYANOCOBALAMIN 1 Oral 0 500 MG QD
120610414 12061041 14 C POTASSIUM POTASSIUM 1 Oral 0 20 MG QD
120610414 12061041 15 C VITAMIN D CHOLECALCIFEROL 1 Oral 0 600 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
120610414 12061041 1 Asthma
120610414 12061041 2 Ill-defined disorder
120610414 12061041 3 Gastrooesophageal reflux disease
120610414 12061041 4 Fluid retention
120610414 12061041 5 Anticoagulant therapy
120610414 12061041 6 Anticoagulant therapy
120610414 12061041 9 Gastrooesophageal reflux disease
120610414 12061041 10 Oedema peripheral
120610414 12061041 11 Oedema peripheral
120610414 12061041 12 Oedema peripheral
120610414 12061041 14 Blood potassium abnormal

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
120610414 12061041 Circumstance or information capable of leading to medication error
120610414 12061041 Device malfunction
120610414 12061041 Dyspnoea
120610414 12061041 Foaming at mouth
120610414 12061041 Off label use
120610414 12061041 Oral discomfort
120610414 12061041 Oropharyngeal pain
120610414 12061041 Peripheral swelling
120610414 12061041 Product taste abnormal
120610414 12061041 Retching
120610414 12061041 Sputum discoloured

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
120610414 12061041 1 201509 0
120610414 12061041 3 2005 0
120610414 12061041 5 2004 0
120610414 12061041 6 2004 0
120610414 12061041 8 2006 0
120610414 12061041 9 2005 0
120610414 12061041 11 2010 0
120610414 12061041 12 2015 0
120610414 12061041 13 2006 0
120610414 12061041 14 2016 0
120610414 12061041 15 2005 0